TrialThe Journal of clinical investigation2020

CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration.

Christopher L Nobles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.